Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Exclusion Criteria

• •1. Severe COVID-19 having oxygen saturation (SpO2) ≤ 93 % on room air at sea level or ratio of arterial oxygen partial pressure (PaO2 in millimeters of mercury) to fractional inspired oxygen (FiO2) \< 300, respiratory rate ≥ 30/min, heart rate ≥ 125/min
• •2. Requires mechanical ventilation or anticipated impending need for mechanical ventilation
• •3. Known allergies to any of the components used in the formulation of the interventions
• •4. Have received an investigational intervention for SARS-CoV-2 prophylaxis within 30 days before dosing
• •5. Have received treatment with a SARS-CoV-2 specific monoclonal antibody